Third, TRPC6 is sensitive to CAI in Hep G2 and Huh-7 human hepatoma cells [19], albeit this drug may also prevent intracellular Ca2+ mobilization in mRCC cells. Here, TRPC6 is linked to hepatocellular carcinoma.